Literature DB >> 22057113

dysregulation of CD1d-restricted type ii natural killer T cells leads to spontaneous development of colitis in mice.

Chia-Min Liao1, Michael I Zimmer, Sharmila Shanmuganad, Hon-Tsen Yu, Susanna L Cardell, Chyung-Ru Wang.   

Abstract

BACKGROUND & AIMS: CD1d-restricted natural killer (NK) T cells are a subset of immunoregulatory T cells that comprise type I (express the semi-invariant T-cell receptor [TCR] and can be detected using the α-galactosylceramide/CD1d tetramer) and type II (express diverse TCRs and cannot be directly identified). Studies in mouse models of inflammatory bowel disease revealed a complex role for type I NKT cells in the development of colitis. Type II NKT cells have been associated with intestinal inflammation in patients with ulcerative colitis.
METHODS: To investigate whether dysregulation of type II NKT cells, caused by increased expression of CD1d, can contribute to colitis, we generated transgenic mice that express high levels of CD1d and a TCR from an autoreactive, type II NKT cell (CD1dTg/24αβTg mice).
RESULTS: CD1dTg/24αβTg mice had reduced numbers of 24αβ T cells compared with 24αβTg mice, indicating that negative selection increases among type II NKT cells engaged by abundant self-antigen. The residual 24αβ T cells in CD1dTg/24αβTg mice had an altered surface phenotype and acquired a cytokine profile distinct from that of equivalent cells in 24αβTg mice. Interestingly, CD1dTg/24αβTg mice spontaneously developed colitis; adoptive transfer experiments confirmed that type II NKT cells that develop in the context of increased CD1d expression are pathogenic.
CONCLUSIONS: Aberrant type II NKT cell responses directly contribute to intestinal inflammation in mice, indicating the importance of CD1d expression levels in the development and regulation of type II NKT cells.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057113      PMCID: PMC3267843          DOI: 10.1053/j.gastro.2011.10.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

Review 1.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

2.  Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice.

Authors:  Y H Chen; N M Chiu; M Mandal; N Wang; C R Wang
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

3.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

4.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Tissue distribution, regulation and intracellular localization of murine CD1 molecules.

Authors:  M Mandal; X R Chen; M L Alegre; N M Chiu; Y H Chen; A R Castaño; C R Wang
Journal:  Mol Immunol       Date:  1998-06       Impact factor: 4.407

6.  CD1d-restricted T cell activation by nonlipidic small molecules.

Authors:  Ildiko Van Rhijn; David C Young; Jin Seon Im; Steven B Levery; Petr A Illarionov; Gurdyal S Besra; Steven A Porcelli; Jenny Gumperz; Tan-Yun Cheng; D Branch Moody
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

7.  Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.

Authors:  M Exley; J Garcia; S P Balk; S Porcelli
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

8.  Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.

Authors:  Alex Jahng; Igor Maricic; Carlos Aguilera; Susanna Cardell; Ramesh C Halder; Vipin Kumar
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

9.  CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells.

Authors:  F M Spada; Y Koezuka; S A Porcelli
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

10.  CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  S Cardell; S Tangri; S Chan; M Kronenberg; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  36 in total

1.  Immune/Inflammatory Response and Hypocontractility of Rabbit Colonic Smooth Muscle After TNBS-Induced Colitis.

Authors:  Yonggang Zhang; Fang Li; Hong Wang; Chaoran Yin; JieAn Huang; Sunila Mahavadi; Karnam S Murthy; Wenhui Hu
Journal:  Dig Dis Sci       Date:  2016-02-15       Impact factor: 3.199

Review 2.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 3.  Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.

Authors:  Suryasarathi Dasgupta; Vipin Kumar
Journal:  Immunogenetics       Date:  2016-07-12       Impact factor: 2.846

4.  The adaptor protein SAP regulates type II NKT-cell development, cytokine production, and cytotoxicity against lymphoma.

Authors:  Xiufang Weng; Chia-Min Liao; Sreya Bagchi; Susanna L Cardell; Paul L Stein; Chyung-Ru Wang
Journal:  Eur J Immunol       Date:  2014-10-28       Impact factor: 5.532

5.  CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice.

Authors:  Sreya Bagchi; Ying He; Hong Zhang; Liang Cao; Ildiko Van Rhijn; D Branch Moody; Johann E Gudjonsson; Chyung-Ru Wang
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

Review 6.  Control of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiota.

Authors:  C Marie Dowds; Richard S Blumberg; Sebastian Zeissig
Journal:  Clin Immunol       Date:  2015-05-16       Impact factor: 3.969

Review 7.  Type II NKT Cells and Their Emerging Role in Health and Disease.

Authors:  Madhav V Dhodapkar; Vipin Kumar
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

Review 8.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

Review 9.  Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces.

Authors:  Sebastian Zeissig; Richard S Blumberg
Journal:  Curr Opin Immunol       Date:  2013-11-05       Impact factor: 7.486

10.  Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.

Authors:  Jie Zhao; Xiufang Weng; Sreya Bagchi; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.